SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-03-021252
Filing Date
2003-09-22
Accepted
2003-09-22 15:57:29
Documents
1
Group Members
AVENTIS HOLDINGS INC.AVENTIS PHARMACEUTICALS INC

Document Format Files

Seq Description Document Type Size
1 SC 13G a03-3544_1sc13g.htm SC 13G 108815
  Complete submission text file 0001104659-03-021252.txt   111104
Mailing Address
Business Address 500 ARCOLA RD P O BOX 1200 M/S 5B14 COLLEGEVILLE PA 19426-0107 6104548000
AVENTIS INC (Filed by) CIK: 0000217028 (see all company filings)

IRS No.: 231699163 | State of Incorp.: PA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701
Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310
INTROGEN THERAPEUTICS INC (Subject) CIK: 0001018710 (see all company filings)

IRS No.: 742704230 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-61001 | Film No.: 03904336
SIC: 2834 Pharmaceutical Preparations